ETDRS Letters
Showing 1 - 25 of 868
Visual Acuity Trial in Hong Kong (Visual acuity assessment by ETDRS charts)
Completed
- Visual Acuity
- Visual acuity assessment by ETDRS charts
-
Hong Kong, Hong KongHKSDS Program
Aug 19, 2020
Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral
Completed
- Wet Age-related Macular Degeneration
- Intravitreal anti-VEGF
- +2 more
-
Boston, Massachusetts
- +1 more
May 24, 2022
Diabetic Macular Edema, Retinal Disease, Macular Edema Trial in United States (Aflibercept, foselutoclax)
Not yet recruiting
- Diabetic Macular Edema
- +8 more
-
Bakersfield, California
- +7 more
Aug 23, 2023
Safety and Effectiveness of Brolucizumab in Diabetic Macular
Not yet recruiting
- Diabetic Macular Edema
- brolucizumab
- (no location specified)
Jul 17, 2023
Diabetic Macular Edema Trial in Beverly Hills (Active treatment arm: OCS-01 (dexamethasone), Vehicle)
Active, not recruiting
- Diabetic Macular Edema
- Active treatment arm: OCS-01 (dexamethasone)
- Vehicle
-
Beverly Hills, CaliforniaOculis Investigative Site
Jan 13, 2023
Brolucizumab in Pre-treated nAMD in the Real-world Setting
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Brolucizumab
- (no location specified)
Aug 8, 2022
Diabetic Macular Edema Trial in China (Brolucizumab, Aflibercept)
Active, not recruiting
- Diabetic Macular Edema
-
Guangzhou, Guangdong, China
- +23 more
Jan 20, 2023
Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative Trial (OCS-01)
Not yet recruiting
- Uveitis Related Cystoid Macular Edema
- Cystoid Macular Edema, Postoperative
- (no location specified)
Nov 1, 2022
Choroideremia, X-Linked Retinitis Pigmentosa Trial in Worldwide (BIIB111, BIIB112)
Enrolling by invitation
- Choroideremia
- X-Linked Retinitis Pigmentosa
- BIIB111
- BIIB112
-
Los Angeles, California
- +22 more
Apr 20, 2022
Learn More About How Well Aflibercept 8 mg Works in Treating
Not yet recruiting
- Visual Impairment
- +2 more
- Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Australia
- +5 more
Oct 4, 2023
Artificial Intelligence Diagnostic Aid
Not yet recruiting
- Wet Macular Degeneration
- +2 more
- Macusense Assessment Software
-
London, Westminster, United KingdomGuy's and St Thomas's NHS Foundation Trust
Dec 29, 2022
Diabetic Retinopathy, Diabetic Cataract Trial in Guangzhou (Pars plana vitrectomy combined with cataract surgery., Pars plana
Completed
- Diabetic Retinopathy
- Diabetic Cataract
- Pars plana vitrectomy combined with cataract surgery.
- Pars plana vitrectomy with subsequent cataract surgery.
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic center, Sun Yat-sen University
Sep 8, 2022
Maximum Treatment Interval With Aflibercept T&E
Recruiting
- Neovascular Age-related Macular Degeneration
- Aflibercept Injection [Eylea]
-
Taipei, TaiwanShin Kong Memorial Wu Ho-Su Hospital
Apr 19, 2022
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
Recruiting
- Retinitis Pigmentosa
- +4 more
-
San Francisco, California
- +4 more
Oct 5, 2022
Rapid Computerized Visual Acuity Test
Recruiting
- Vision Disorders
- +4 more
- Computerized visual acuity assessment program
-
Haifa, IsraelDepartment of Ophthalmology at Rambam Health Care Campus
Jul 3, 2022
Prediction of Progression of Retinal Ischemia in Diabetes
Recruiting
- Diabetic Retinopathy
-
Coimbra, PortugalAIBILI-CEC (AIBILI- Clinical Trials Centre)
Dec 21, 2022
Diabetic Macular Edema, Pars Plana Vitrectomy, Dexamethasone Intravitreal Implant Trial in Tianjin (Ozurdex, Aflibercept)
Not yet recruiting
- Diabetic Macular Edema
- +3 more
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Aug 6, 2023
IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting
- Cataract
- +2 more
-
Dothan, Alabama
- +10 more
Sep 23, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Austin, TexasRetina Consultants of Austin
Jan 16, 2023
Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)
Not yet recruiting
- Uveitis
- +3 more
- Yutiq 0.18 MG Drug Implant
- Sham Injection
-
Plano, TexasTexas Retina Associates
Aug 3, 2022
Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML
Withdrawn
- Wet Macular Degeneration
- Aflibercept 40 MG/ML [Eylea]
- +2 more
-
Prague, CzechiaDepartment of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022